{"nct_id":"NCT03724916","title":"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2018-11-26","start_date_type":"ACTUAL","primary_completion_date":"2021-11-04","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}